Rising demand for health care combined with the graduated introduction of the National Health Insurance Scheme (Seha) look set to boost Qatar’s nascent pharmaceuticals and medical products segment.
Health
Displaying 91 - 96 of 147
Plans to increase the production and distribution of generic drugs in South Africa are gathering pace, paving the way for the government to push ahead with the phased rollout of its National Health Insurance (NHI) scheme.
A two-pronged drive to tackle the rise of lifestyle diseases in Oman and broaden the range of medical facilities available locally has put the country’s health care services on course for rapid growth.
As Kuwait moves forward on health care reforms aimed at expanding service provision for its rapidly growing population, the private sector is set to play a more prominent role in the industry. While free health care is guaranteed to all Kuwaiti citizens, population growth has put considerable strain on state-owned facilities. The government has recently announced a number of new projects slated to be constructed across the country, with public-private partnerships (PPPs) expected to bolster service quality and provision for Kuwait’s 3.25m residents.
A flurry of new deals signed in the first quarter of 2014 are set to push up trade between Bahrain and India, while also paving the way for the Kingdom to continue expanding its health care sector and pharmaceuticals industry.
The introduction of pharmaceutical price controls is the latest move by the Colombian government in its commitment to reduce health care costs, while the pharmaceutical industry claims that faces unfair competition from generic drugs and the lack of incentives afflicting to invest in research facilities.